BioSpace News Archive

Retrophin, Inc. announced that on February 10, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 22,500 shares of its common stock to three new employees and granted inducement restricted stock units, or RSUs, covering an aggregate of 8,000 shares of its common stock to seven new employees.

Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the 9th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, on Thursday, February 27, 2020 at 10:00 a.m.

A tiny molecule of RNA – known as ‘micro RNA’ – plays a key role in ‘rewiring’ cancer cells so they can resist the effects of chemotherapy, a new study reveals.

International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces that it is hosting a symposium to drive the debate: Are Randomized Clinical Trials Obsolete?

Pulse Biosciences, Inc., a novel bioelectric medicine company, announced an update on its U.S. Food and Drug Administration submission for the CellFX System.

Deciphera Pharmaceuticals, Inc. announced the pricing of its previously announced registered underwritten public offering of 3,181,818 shares of its common stock at a price to the public of $55.00 per share.

Bio-Rad Laboratories, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.

BioMatrix Specialty Pharmacy announced today they have been named one of the Best and Brightest Companies to Work For® by the National Association for Business Resources (NABR)

In response to the increasingly diverse ecosystem developing in one of the leading districts of its kind in the country, Innovation Quarter today announced new branding, including a new interactive website, a redesigned logo and a simplifying of its name, shifting from Wake Forest Innovation Quarter to Innovation Quarter.

Cybernet is excited to announce the world’s first fully antimicrobial medical computer.